EUVIMEDOpdag EUVIMED
Open access

Projections of Lung Cancer Incidence by 2035 in 40 Countries Worldwide: Population-Based Study

Ganfeng Luo iD, Yanting Zhang iD, Jaione Etxeberria iD, Melina Arnold iD, Xiuyu Cai iD, Yuantao Hao iD, Huachun Zou iD

JMIR Public Health and Surveillance · 2023-02-17 · 9 · e43651

DOI: 10.2196/43651 ↗

At a glance

Journal article in JMIR Public Health and Surveillance, published online on 2023-02-17. Written by Ganfeng Luo and 6 co-authors. Institution: School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China. Major MEDLINE topics: Lung Neoplasms. Cited 170 times so far (Crossref); 56 references. The full text is freely available in PubMed Central. Funded by: World Health Organization.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The global burden of lung cancer (LC) is increasing. Quantitative projections of the future LC burden in different world regions could help optimize the allocation of resources and provide a benchmark for evaluating LC prevention and control interventions.

Objective

We aimed to predict the future incidence of LC in 40 countries by 2035, with an emphasis on country- and sex-specific disparities.

Methods

Data on LC incidence from 1978 to 2012 were extracted from 126 cancer registries of 40 countries in Cancer Incidence in Five Continents Volumes V-XI and used for the projection. Age-standardized incidence rates (ASRs) per 100,000 person-years and the number of incident cases were predicted through 2035, using the NORDPRED age-period-cohort model.

Results

Global ASRs of the 40 studied countries were predicted to decrease by 23% (8.2/35.8) among males, from 35.8 per 100,000 person-years in 2010 to 27.6 in 2035, and increase by 2% (0.3/16.8) among females, from 16.8 in 2010 to 17.1 in 2035. The ASRs of LC among females are projected to continue increasing dramatically in most countries by 2035, with peaks after the 2020s in most European, Eastern Asian, and Oceanian countries, whereas the ASRs among males will continue to decline in almost all countries. The ASRs among females are predicted to almost reach those among males in Ireland, Norway, the United Kingdom, the Netherlands, Canada, the United States, and New Zealand in 2025 and in Slovenia in 2035 and even surpass those among males in Denmark in 2020 and in Brazil and Colombia in 2025. In 2035, the highest ASRs are projected to occur among males in Belarus (49.3) and among females in Denmark (36.8). The number of new cases in 40 countries is predicted to increase by 65.32% (858,000/1,314,000), from 1.31 million in 2010 to 2.17 million in 2035. China will have the largest number of new cases.

Conclusions

LC incidence is expected to continue to increase through 2035 in most countries, making LC a major public health challenge worldwide. The ongoing transition in the epidemiology of LC highlights the need for resource redistribution and improved LC control measures to reduce future LC burden worldwide.

Subjects

MeSH terms (MEDLINE)

Lung NeoplasmsMaleFemaleHumansUnited StatesIncidenceChinaNew ZealandForecasting

Author keywords

incidencelung cancerprojectionstemporal trendsworldwide

Authors and institutions

  • School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.
  • Department of Medical Statistics, School of Public Health, Sun Yat-sen University, Guangzhou, China.
  • Department of Epidemiology and Health Statistics, School of Public Health, Guangdong Medical University, Dongguan, China.
  • Department of Statistics, Computer Science and Mathematics, Public University of Navarre, Navarre, Spain.
  • Institute for Advanced Materials and Mathematics (INAMAT2), Public University of Navarre, Navarre, Spain.
  • Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.

ORCID profiles: Ganfeng Luo, Yanting Zhang, Jaione Etxeberria, Melina Arnold, Xiuyu Cai, Yuantao Hao, Huachun Zou

Funding

  • World Health Organization

Cite

APA

Luo, G., Zhang, Y., Etxeberria, J., Arnold, M., Cai, X., Hao, Y., & Zou, H. (2023). Projections of Lung Cancer Incidence by 2035 in 40 Countries Worldwide: Population-Based Study. JMIR Public Health and Surveillance, 9, e43651. https://doi.org/10.2196/43651

Vancouver

Luo G, Zhang Y, Etxeberria J, Arnold M, Cai X, Hao Y, et al. Projections of Lung Cancer Incidence by 2035 in 40 Countries Worldwide: Population-Based Study. JMIR Public Health and Surveillance. 2023;9:e43651. doi:10.2196/43651

BibTeX
@article{Luo2023,
  author = {Luo, Ganfeng and Zhang, Yanting and Etxeberria, Jaione and Arnold, Melina and Cai, Xiuyu and Hao, Yuantao and Zou, Huachun},
  title = {Projections of Lung Cancer Incidence by 2035 in 40 Countries Worldwide: Population-Based Study},
  journal = {JMIR Public Health and Surveillance},
  year = {2023},
  volume = {9},
  pages = {e43651},
  doi = {10.2196/43651}
}
Start for free →